Status:
RECRUITING
Ethanol Sclerotherapy Prior to ART
Lead Sponsor:
Ankara University
Collaborating Sponsors:
Hacettepe University
Conditions:
Endometrioma
Infertility
Eligibility:
FEMALE
18-40 years
Phase:
NA
Brief Summary
The goal of this randomized controlled trial is to assess the impact of ethanol sclerotherapy on ART cycle outcomes. The main questions it aims to answer are: 1. Does ethanol sclerotherapy before ART...
Detailed Description
The effect of ethanol sclerotherapy before assisted reproductive technology (ART) cycle in patients with endometrioma on reproductive outcomes will be investigated. While endometrioma may result in te...
Eligibility Criteria
Inclusion
- AMH\>0.3 ng/ml
- unilateral/bilateral endometrioma
- Endometrioma diameter 40-100 mm
Exclusion
- 3 or more IVF/embryo transfer failure
- Menstrual cycle abnormalities
- Male Factor infertility
- Presence of uterine fibroids
- Presence of hydrosalpinx
- Presence of uterine abnormalities
- Suspicion of malignancy according to International Ovarian Tumor Analysis criteria
Key Trial Info
Start Date :
May 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2026
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT05962775
Start Date
May 1 2023
End Date
April 1 2026
Last Update
October 16 2024
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Başkent University Adana IVF Center
Adana, Turkey (Türkiye)
2
Ankara University School of Medicine, Department of Obstetrics and Gynecology
Ankara, Turkey (Türkiye), 06610
3
Bahçeci IVF Clinic
Istanbul, Turkey (Türkiye)